Fusion Antibodies plc (AIM:FAB)

Fusion Antibodies Revenue

In the fiscal year ending March 31, 2025, Fusion Antibodies had annual revenue of 1.97M GBP with 72.98% growth. Fusion Antibodies had revenue of 758.00K in the half year ending March 31, 2025, a decrease of -26.97%.

• Revenue: 1.97M
• Revenue Growth: +72.98%
• P/S Ratio: 7.95
• Revenue / Employee: 81.88K
• Employees: 24
• Market Cap: 15.63M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.97M	829.00K	72.98%
Mar 31, 2024	1.14M	-1.77M	-60.84%
Mar 31, 2023	2.90M	-1.90M	-39.55%
Mar 31, 2022	4.80M	634.00K	15.22%
Mar 31, 2021	4.17M	270.00K	6.93%